Your most critical assets deserve more than just fences and cameras. NV5’s cutting-edge layered security solutions extend detection and response beyond traditional perimeters. From advanced geospatial analytics to integrated surveillance and access control, NV5 helps you stay ahead of threats before they breach your defenses. Learn more.

Learn More

Research & Applications

SHINE's final SER for Wisconsin facility issued by NRC

March 1, 2023, 12:00PMNuclear News
SHINE’s isotope production building, called the Chrysalis, under construction in October 2022. (Photo: SHINE)

The Nuclear Regulatory Commission has issued its final safety evaluation report (SER) related to the operating license application for SHINE Technologies' large-scale medical isotope production facility, known as The Chrysalis, in Janesville, Wis. The SER documents the results of NRC staff’s technical and safety review of SHINE’s application. SHINE announced the NRC’s decision on February 27.

A record of decision concerning the proposed issuance of the operating license will be published by the NRC at a future date.

To continue reading, log in or create a free account!

Related Articles

New financing round benefits Valar

November 13, 2025, 3:00PMNuclear News

Hawthorne, Calif.–based reactor start-up Valar Atomics recently announced that it has raised $130 million in its Series A funding round, led by venture capital groups Snowpoint, Day One, and...

X-energy begins irradiation testing at INL

November 12, 2025, 3:01PMNuclear News

Advanced reactor and fuel developer X-energy has officially begun confirmatory irradiation testing at Idaho National Laboratory on its TRISO-X fuel. The testing, which is taking place over the...